Brief: Yichang Hec Changjiang Pharmaceutical Sees A Net Loss Attributable Of About RMB546 Million To RMB630 Million For Year

Yichang Hec Changjiang Pharmaceutical Co

11/03/2022 10:09

March 11 (Reuters) - YiChang HEC ChangJiang Pharmaceutical
Co Ltd  1558.HK :
    * SEES  A NET LOSS ATTRIBUTABLE OF APPROXIMATELY RMB546
MILLION TO
APPROXIMATELY RMB630 MILLION FOR YEAR
    * SEES NET LOSS ATTRIBUTABLE EX ITEMS OF RMB384 MILLION TO
RMB443
MILLION FOR YEAR
    * EXPECTED RESULT DUE TO DOMESTIC PANDEMIC PREVENTION &
CONTROL
MEASURES WERE SEVERE AFTER OUTBREAK OF COVID-19

Further company coverage:  1558.HK 

 ((Reuters.Briefs@thomsonreuters.com;))